Clinicians > mCRC Clinical Studies > Right-Sided mCRC >
Study Overview


Primary tumour location was captured prospectively for 739 patients in the SIRFLOX and FOXFIRE Global studies:

  • Right-sided primary (RSP) tumours were defined as any primary tumour proximal to the splenic flexure
  • Left-sided primary (LSP) tumours included any primary tumour at the splenic flexure, the more distal colon or the rectum

Overall survival and progression-free survival data were examined independently for patients with RSP and LSP.

Tumour response was determined according to Response Evaluation Criteria In Solid Tumours (RECIST) version 1.0.

All analyses were performed on the intention-to-treat population.

Gibbs P et al.  Clin Col Cancer 2018 Jun 12 ePub: doi: 10.1016/j.clcc.2018.06.001.


Now leaving sirtex.com

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.

Continue

×

You are now leaving your current sirtex.com region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.

Continue

×

This content is intended for healthcare professionals only

By clicking "Yes" you are confirming that you are a healthcare professional. If you are not a healthcare professional, then please click "Go to Homepage" which will direct you to the Sirtex homepage.

Yes Go to Homepage